GlobeImmune (GBIM) Priced

Developing therapeutic drugs for pancreatic cancer and hepatitis B and C.

Health Care - Biotechnology

IPO Performance
Latest Trade $0.16 -0.03 (-15.8%)
First Day Return 10.5%
Return from IPO -98.1%
 
GlobeImmune IPO News more
  • .
IPO Data
IPO File Date 03/17/2014
Offer Price $10.00
Price Range $15.00 - $15.00
Offer Shares (mm) 1.5
Deal Size ($mm) 15
 
IPO Data
IPO Date 07/01/2014
Offer Price $10.00
Price Range $15.00 - $15.00
Offer Shares (mm) 1.5
Deal Size ($mm) $15
 
Underwriters
more
Business Overview
Developing therapeutic drugs for pancreatic cancer and hepatitis B and C.
Developing therapeutic drugs for pancreatic cancer and hepatitis B and C.
more
Company Data
Headquarters Louisville, CO
Founded 1995
Employees 25
Website www.globeimmune.com
 

Performance vs. IPO Index (IPOUSA)